US 9561256
LLP2A-bisphosphonate conjugates for osteoporosis treatment
granted A61KA61K31/00A61K31/66
Quick answer
US patent 9561256 (LLP2A-bisphosphonate conjugates for osteoporosis treatment) held by The Regents of the University of California expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/00, A61K31/66, A61K31/661, A61K31/663